Valuation: Haleon plc

Market Cap 31.32B 42.46B 36.66B 34.39B 58.9B 4,060B 59.72B 403B 158B 2,034B 159B 156B 6,766B P/E 2026 *
18.5x
P/E 2027 * 16.3x
Enterprise Value 38.19B 51.77B 44.69B 41.93B 71.81B 4,950B 72.8B 492B 193B 2,480B 194B 190B 8,249B EV / Sales 2026 *
3.35x
EV / Sales 2027 * 3.18x
Free-Float
98.47%
Yield 2026 *
2.27%
Yield 2027 * 2.52%
1 day-1.31%
1 week-4.11%
Current month-3.61%
1 month-6.19%
3 months+3.89%
6 months-14.36%
Current year-6.56%
1 week 350.2
Extreme 350.2
367.8
1 month 350.2
Extreme 350.2
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-4.11%-2.86%+7.41% 42.44B
+0.71%-3.36%+70.56%+121.44% 1,052B
+0.51%+0.01%+48.56%+50.47% 627B
+0.32%+0.80%+21.00%+66.61% 441B
+0.28%-4.56%+39.10%+38.05% 349B
+0.78%-2.68%+23.13%+37.32% 287B
+0.87%-3.59%-1.52%+7.12% 241B
+0.20%-0.37%+42.05%+57.54% 224B
-0.78%-4.49%-15.86%-54.13% 202B
+0.26%+4.13%+17.43%+81.11% 172B
Average +0.07%-1.07%+24.16%+41.29% 363.76B
Weighted average by Cap. +0.35%-0.66%+39.31%+63.42%

Financials

2026 *2027 *
Net sales 11.39B 15.44B 13.33B 12.51B 21.42B 1,477B 21.72B 147B 57.46B 740B 57.98B 56.73B 2,461B 11.87B 16.1B 13.9B 13.04B 22.33B 1,539B 22.64B 153B 59.88B 771B 60.43B 59.12B 2,565B
Net income 1.7B 2.3B 1.99B 1.86B 3.19B 220B 3.23B 21.84B 8.56B 110B 8.64B 8.45B 367B 1.92B 2.6B 2.25B 2.11B 3.61B 249B 3.66B 24.72B 9.69B 125B 9.78B 9.56B 415B
Net Debt 6.86B 9.31B 8.03B 7.54B 12.91B 890B 13.09B 88.35B 34.62B 446B 34.94B 34.18B 1,483B 6.42B 8.71B 7.52B 7.05B 12.08B 833B 12.25B 82.68B 32.4B 417B 32.7B 31.99B 1,388B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-08-17 GBX 350.20 -1.52% 8,670,624
26-08-14 GBX 355.60 -0.64% 6,422,346
26-08-13 GBX 357.90 -0.56% 13,056,164
26-08-12 GBX 359.90 -1.51% 13,624,912
26-08-11 GBX 365.40 +0.05% 13,876,145
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.556GBP
Average target price
4.208GBP
Spread / Average Target
+18.34%

Quarterly revenue - Rate of surprise